Preparation and preliminary evaluation of a tris-metronidazole-99mTc(CO)3 complex for targeting tumor hypoxia
- 17 July 2018
- journal article
- research article
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 317 (3) , 1203-1210
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- 99mTc/Re complexes bearing bisnitroimidazole or mononitroimidazole as potential bioreductive markers for tumor: Synthesis, physicochemical characterization and biological evaluationEuropean Journal of Medicinal Chemistry, 2012
- Molecular imaging of hypoxia with radiolabelled agentsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Hypoxia Positron Emission Tomography Imaging With 18F-FluoromisonidazoleSeminars in Nuclear Medicine, 2007
- Synthesis and preliminary biological evaluation of the 99mTc labeled nitrobenzoimidazole and nitrotriazole as tumor hypoxia markersBioorganic & Medicinal Chemistry Letters, 2006
- Imaging hypoxia in tumorsSeminars in Nuclear Medicine, 2001
- A Novel Organometallic Aqua Complex of Technetium for the Labeling of Biomolecules: Synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in Aqueous Solution and Its Reaction with a Bifunctional LigandJournal of the American Chemical Society, 1998
- A neutral lipophilic complex of 99mTc with a multidentate amine oximeThe International Journal of Applied Radiation and Isotopes, 1984
- Correlation of the Efficiencies of Some Radiation Sensitizers and Their Redox PotentialsInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1974
- Hydrated electrons and radiobiological sensitisationBiochemical and Biophysical Research Communications, 1963
- The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in RadiotherapyBritish Journal of Radiology, 1953